Edward M. Behrens

2016 Classification Criteria for Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis

C. Wouters, N. Wulffraat, R. Schneider, 2016, Annals of the rheumatic diseases.

Disease course, treatments, and outcomes of children with systemic juvenile idiopathic arthritis associated lung disease (SJIA-LD).

Alex V. Pickering, M. Stoll, A. Hersh, 2023, Arthritis care & research.

Successful treatment of severe paediatric rheumatic disease-associated macrophage activation syndrome with interleukin-1 inhibition following conventional immunosuppressive therapy: case series with 12 patients.

R. Cron, E. Behrens, A. Narendran, 2011, Rheumatology.

Genetic Defects in Cytolysis in Macrophage Activation Syndrome

R. Cron, E. Behrens, T. Atkinson, 2014, Current Rheumatology Reports.

Patient-reported Outcomes across Categories of Juvenile Idiopathic Arthritis

E. Wileyto, E. Behrens, P. Weiss, 2015, The Journal of Rheumatology.

Cytokine Storm Syndrome

G. Koretzky, E. Behrens, R. Cron, 2019 .

Hyperferritinemia screening to aid identification and differentiation of patients with hyperinflammatory disorders

S. Canna, K. Kernan, Paul Tsoukas, 2024, Research square.